Physician profile
John Kripsak
NPI 1275576910
$1,458.08
in general payments reported to CMS, 2019-2025
19 companies · $495 in 2025
The $495 reported for 2025 was more than what 83% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.63 · 2020: $37.38 · 2021: $110 · 2022: $291 · 2023: $192 · 2024: $301 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $313.86 | 2021-2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $220.47 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $179.41 | 2022-2025 | |
| Abbvie INC. | $156.18 | 2021-2025 | |
| Depuy Synthes Sales INC. | $96.48 | 2020-2025 | Orthovisc, Monovisc |
| Exact Sciences Corporation | $88.51 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $83.91 | 2022-2024 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $64.27 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $60.84 | 2021-2025 | Airsupra, Breztri |
| Abbott Laboratories | $36.00 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Stryker Corporation | $30.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.05 | 2022 | |
| Althera Pharmaceuticals LLC | $18.19 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.01 | 2025 | Jardiance |
| Braintree Laboratories, INC. | $16.97 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.65 | 2022 | |
| Qol Medical, LLC | $14.35 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.19 | 2022 | |
| Allergan, INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kripsak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.